DigiPath Selected as Laboratory Testing Service Provider for Moxie Seeds & Extracts Licensee, Green Therapeutics

NEW YORK, NY--(Marketwired - Aug 10, 2016) -  DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), an independent cannabis lab testing and media firm, is pleased to announce it has been selected as the laboratory testing service provider for Green Therapeutics (GT), a licensed cannabis cultivator and producer with facilities located in North Las Vegas and Clark County, Nevada.

GT is the exclusive Nevada licensee of Moxie Seeds & Extracts, one of the leading cannabis extract producers in the United States with over 50 cannabis cup wins. Moxie produces a variety of extracts, including waxes, shatters, oils, hashes, and tinctures, as well as sells seeds for a range of cannabis strains.

Mike Tulimero, Operations Manager at Moxie, said, "We looked at all of the testing labs in Las Vegas and concluded that DigiPath Labs had the most to offer. They have a great staff of scientists, deliver results in only 48 hours, and their customer service is second to none."

DigiPath Labs' state-of-the-art Las Vegas laboratory was developed to elevate the standard for cannabis testing. The team carefully selected equipment and verified standard operating procedures to ensure reliable, replicable results. DigiPath is honored to have been chosen as the laboratory-testing provider for such a well-renowned brand.

Todd Denkin, President of DigiPath, commented, "Moxie is very popular in California and we are excited to be testing this brand as it is introduced to the Nevada market. They have built a strong working relationship with the local group at Green Therapeutics, and we look forward to help keeping them safe."

To learn more about DigiPath Labs, visit www.digipathlabs.com.

About DigiPath, Inc.
DigiPath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. DigiPath's two business units are DigiPath Labs and TNM News Corp. DigiPath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis. 

For more information please visit http://www.digipath.com/.

Forward-Looking Statements
This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, governmental regulation of the cannabis industry, the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.